Collaboration between Sanofi and Joslin Diabetes Center to focus on new drugs for diabetes
19 June 2012 | By Sanofi
Sanofi and the Joslin Diabetes Center announced a new collaboration...
List view / Grid view
19 June 2012 | By Sanofi
Sanofi and the Joslin Diabetes Center announced a new collaboration...
18 June 2012 | By Merck
Geisinger & Merck enter a new multi-year collaboration...
18 June 2012 | By Gilead Sciences
Gilead Sciences announced that its MAA for elvitegravir has been validated by the EMA...
18 June 2012 | By Pfizer
Tafamidis is a novel, investigational medication for the treatment of TTR-FAP...
18 June 2012 | By Boehringer Ingelheim
Boehringer Ingelheim BioXcellence: Distinctive brand for the biopharmaceutical contract manufacturing business...
18 June 2012 | By Abbott
Results from five abstracts announced...
18 June 2012 | By Boehringer Ingelheim
Pradaxa® is associated with a substantially shorter interruption of oral anticoagulation therapy...
18 June 2012 | By ALM Communications Inc.
Dave Foran, President of USON, is pleased to announce the appointment of Gene Grilli to be USON Global Sales Director...
18 June 2012 | By ALM Communications Inc.
USON, announces the appointment of an award-winning veteran of the automated instrumentation industry, Charles D. Foran Jr. (Dave), as USON President...
Lonza, a global leader in the field of biologics manufacturing, today announced the successful completion of its new GMP clean room within its Houston, Texas operations. The clean room supports multiple types of viral vector and viral vaccine projects, with working volumes up to 2,000 liters.
15 June 2012 | By Merck
"While we are pleased with the court's ruling that the patent for NASONEX is valid..."
15 June 2012 | By GlaxoSmithKline
GSK has received a renewed invitation from Human Genome Sciences’...
15 June 2012 | By Roche
Over 20,000 employees of Roche marked the International Day of the African Child...
15 June 2012 | By Pfizer
Pfizer has announced the launch of a new Web site, “Campaign Against Migraine”, to help migraine sufferers across the country...
14 June 2012 | By GlaxoSmithKline
First combination vaccine to help prevent meningococcal serogroups C and Y and Hib disease...